Literature DB >> 6772907

The in vitro loss of penicillamine in plasma, albumin solutions, and whole blood: implications for pharmacokinetic studies of penicillamine.

R F Bergstrom, D R Kay, J G Wagner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6772907     DOI: 10.1016/0024-3205(80)90137-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  6 in total

1.  D-penicillamine metabolism: the role of transformation in blood plasma.

Authors:  D A Joyce; B R Murphy
Journal:  Agents Actions       Date:  1990-11

2.  Conversion in vitro of urinary (+)-penicillamine to its major metabolites, PSSP and PSSC.

Authors:  G Carruthers; D Weir; D Freeman; M Harth
Journal:  Br J Clin Pharmacol       Date:  1983-06       Impact factor: 4.335

Review 3.  Clinical pharmacokinetics of D-penicillamine.

Authors:  P Netter; B Bannwarth; P Péré; A Nicolas
Journal:  Clin Pharmacokinet       Date:  1987-11       Impact factor: 6.447

4.  D-penicillamine and D-penicillamine-protein disulphide in plasma and synovial fluid of patients with rheumatoid arthritis.

Authors:  D A Joyce; R O Day
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

5.  The pharmacokinetics of penicillamine in a female mongrel dog.

Authors:  R F Bergstrom; R D Kay; J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1981-10

6.  D-penicillamine metabolism in an in-vivo model of inflamed synovium.

Authors:  D A Joyce; M J Forrest; P M Brooks
Journal:  Agents Actions       Date:  1988-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.